To exploit nutrient deprivation as anti-cancer therapy, we investigated the effects of the anti-metabolite 2-deoxy-D-glucose on breast cancer cells in vitro. This compound has been shown to ...

In a recent article posted to the bioRxiv* preprint server, scientists demonstrated the use of 2-deoxy-D-glucose (2-DG) as a wide-spectrum antiviral agent targeting viruses such as severe acute ...

2-deoxy-D-glucose (2DG) is known as a synthetic inhibitor of glucose. 2DG regulates various cellular responses including proliferation, apoptosis and differentiation by regulation of glucose ...

In April 2020, the scientists at INMAS-DRDO and CCMB, Hyderabad jointly conducted laboratory experiments and concluded that the molecule works effectively against the SARS-CoV-2 virus and inhibits ...

The Institute of Nuclear Medicine and Allied Sciences (INMAS), a lab of DRDO has developed the drug 2-deoxy-D-glucose (2-DG), in collaboration with Dr Reddy’s Laboratories, Hyderabad for ...

2. The clinical trials of the medicine called 2-deoxy-D-glucose (2-DG) had shown that it helped in faster recovery of hospitalised patients and also reduced supplemental oxygen dependence. 3. The 2-DG ...

DRDO's newly launched anti-COVID medicine, 2-deoxy-D-glucose is being hailed as an innovative holy grail for COVID patients in India right now, who are currently battling for their lives and ...

(Raj K Raj/HT PHOTO) The Institute of Nuclear Medicine and Allied Sciences (INMAS) has developed an anti-covid-19 therapeutic application of the drug 2-deoxy-D-glucose (2-DG) that helps in faster ...

Four Covid patients in Nashik became the first in the city to be treated with the 2-deoxy-D-glucose (2-DG) oral drug in June. The treatment has shown good results. Dr Chopda said that the drug is ...